High-intensity focused ultrasound as a trackless, noninvasive method of ablating tissue has been a concept with potential for more than 60 years. It is only in the past 10 to…
The 5-year survival for all stages of nonsmall cell lung cancer (NSCLC) remains bleak, having increased from 13% to just 16% over the past 30 years. Despite promising results in…
Metastatic disease is the most common neoplasm involving the skeletal system and can result in significant pain and morbidity. Although narcotic medications and external beam radiation therapy remain the standard…
While surgical excision remains the gold standard for curative treatment of small renal cell carcinomas, ablative therapy has a place as a minimally invasive, kidney function–preserving therapy in carefully selected…
Minimally invasive ablative therapy techniques are being used in research protocols to treat benign and malignant tumors of the breast in select patient populations. These techniques offer the advantages of…
CTs or MRIs are essential for preablative therapy planning of hepatic tumors to identify accurate size, number, and location of tumors. Tumors larger than 5 cm and located near the…
Radiofrequency ablation (RFA), usually performed under percutaneous ultrasound guidance, is considered the gold standard among minimally invasive therapies. On the strength of some recent randomized trials, its indications include operable…
Neuroendocrine cancer commonly metastasizes to the liver and often presents as unresectable disease. Liver resection or debulking most of the tumor provides a survival advantage for patients. Whether used alone…
Ablative therapies remain a useful adjunct in the multidisciplinary treatment of patients with colorectal liver metastases not amenable to hepatic resection. This review summarizes the rationale, underlying mechanisms, techniques, complications,…
Thermal ablation, which induces irreversible cellular injury from focal high-temperature tissue heating that is generated from a focal energy source, has become an accepted treatment option for focal primary and…
